{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:55:43Z","timestamp":1788400543528,"version":"build-2803163510"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Non-alcoholic fatty liver disease (NAFLD) comprises a range of chronic liver diseases that result from the accumulation of excess triglycerides in the liver, and which, in its early phases, is categorized NAFLD, or hepato-steatosis with pure fatty liver. The mortality rate of non-alcoholic steatohepatitis (NASH) is more than NAFLD; therefore, diagnosing the disease in its early stages may decrease liver damage and increase the survival rate. In the current study, we screened the gene expression data of NAFLD patients and control samples from the public dataset GEO to detect DEGs. Then, the correlation betweenbetween the top selected DEGs and clinical data was evaluated. In the present study, two GEO datasets (GSE48452, GSE126848) were downloaded. The dysregulated expressed genes (DEGs) were identified by machine learning methods (Penalize regression models). Then, the shared DEGs between the two training datasets were validated using validation datasets. ROC-curve analysis was used to identify diagnostic markers. R software analyzed the interactions between DEGs, clinical data, and fatty liver. Ten novel genes, including <jats:italic>ABCF1, SART3, APC5, NONO, KAT7, ZPR1, RABGAP1, SLC7A8, SPAG9,<\/jats:italic> and <jats:italic>KAT6A<\/jats:italic> were found to have a differential expression between NAFLD and healthy individuals. Based on validation results and ROC analysis, <jats:italic>NR4A2<\/jats:italic> and <jats:italic>IGFBP1b<\/jats:italic> were identified as diagnostic markers. These key genes may be predictive markers for the development of fatty liver. It is recommended that these key genes are assessed further as possible predictive markers during the development of fatty liver.<\/jats:p>","DOI":"10.1038\/s41598-023-46711-x","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T15:02:36Z","timestamp":1700665356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Bioinformatics analysis and machine learning approach applied to the identification of novel key genes involved in non-alcoholic fatty liver disease"],"prefix":"10.1038","volume":"13","author":[{"given":"Elham","family":"Nazari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazaleh","family":"Khalili-Tanha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Asadnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazaleh","family":"Pourali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Maftooh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Khazaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mahdi","family":"Hassanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Ghayour-Mobarhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon A.","family":"Ferns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Avan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,22]]},"reference":[{"key":"46711_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1155\/2016\/2862173","volume":"2016","author":"J Yu","year":"2016","unstructured":"Yu, J., Marsh, S., Hu, J., Feng, W. & Wu, C. The pathogenesis of nonalcoholic fatty liver disease: Interplay between diet, gut microbiota, and genetic background. Gastroenterol. Res. Pract. 2016, 13 (2016).","journal-title":"Gastroenterol. Res. Pract."},{"issue":"1","key":"46711_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1), 73\u201384 (2016).","journal-title":"Hepatology"},{"key":"46711_CR3","first-page":"321","volume-title":"Non-alcoholic Fatty Liver Disease: A Global Public Health Issue","author":"E Kaya","year":"2020","unstructured":"Kaya, E. & Yilmaz, Y. Non-alcoholic Fatty Liver Disease: A Global Public Health Issue 321\u2013333 (Springer, 2020)."},{"issue":"2","key":"46711_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3748\/wjg.v25.i2.163","volume":"25","author":"N Tanaka","year":"2019","unstructured":"Tanaka, N. et al. Current status, problems, and perspectives of non-alcoholic fatty liver disease research. World J. Gastroenterol. 25(2), 163 (2019).","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"46711_CR5","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1053\/gast.2001.23256","volume":"120","author":"AJ Sanyal","year":"2001","unstructured":"Sanyal, A. J. et al. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120(5), 1183\u20131192 (2001).","journal-title":"Gastroenterology"},{"issue":"1","key":"46711_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes, C., Razavi, H., Loomba, R., Younossi, Z. & Sanyal, A. J. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 67(1), 123\u2013133 (2018).","journal-title":"Hepatology"},{"issue":"8","key":"46711_CR7","first-page":"1007","volume":"46","author":"P Mirmiran","year":"2017","unstructured":"Mirmiran, P., Amirhamidi, Z., Ejtahed, H.-S., Bahadoran, Z. & Azizi, F. Relationship between diet and non-alcoholic fatty liver disease: A review article. Iran. J. Public Health 46(8), 1007 (2017).","journal-title":"Iran. J. Public Health"},{"issue":"3","key":"46711_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/biology11030365","volume":"11","author":"S Koppad","year":"2022","unstructured":"Koppad, S., Basava, A., Nash, K., Gkoutos, G. V. & Acharjee, A. Machine learning-based identification of colon cancer candidate diagnostics genes. Biology 11(3), 365 (2022).","journal-title":"Biology"},{"issue":"5","key":"46711_CR9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1136\/gutjnl-2017-315691","volume":"67","author":"SH Ibrahim","year":"2018","unstructured":"Ibrahim, S. H., Hirsova, P. & Gores, G. J. Non-alcoholic steatohepatitis pathogenesis: Sublethal hepatocyte injury as a driver of liver inflammation. Gut 67(5), 963\u2013972 (2018).","journal-title":"Gut"},{"issue":"2","key":"46711_CR10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","volume":"53","author":"V Ratziu","year":"2010","unstructured":"Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C. & Marchesini, G. A position statement on NAFLD\/NASH based on the EASL 2009 special conference. J. Hepatol. 53(2), 372\u2013384 (2010).","journal-title":"J. Hepatol."},{"issue":"3","key":"46711_CR11","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/hep.30161","volume":"69","author":"D Kim","year":"2019","unstructured":"Kim, D. et al. Changing trends in etiology-based and ethnicity-based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States. Hepatology 69(3), 1064\u20131074 (2019).","journal-title":"Hepatology"},{"issue":"7","key":"46711_CR12","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s00535-020-01684-w","volume":"55","author":"TG Cotter","year":"2020","unstructured":"Cotter, T. G. et al. Nonalcoholic fatty liver disease: Impact on healthcare resource utilization, liver transplantation and mortality in a large, integrated healthcare system. J. Gastroenterol. 55(7), 722\u2013730 (2020).","journal-title":"J. Gastroenterol."},{"issue":"9615","key":"46711_CR13","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","volume":"371","author":"D Schuppan","year":"2008","unstructured":"Schuppan, D. & Afdhal, N. H. Liver cirrhosis. The Lancet 371(9615), 838\u2013851 (2008).","journal-title":"The Lancet"},{"issue":"2","key":"46711_CR14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3748\/wjg.v20.i2.475","volume":"20","author":"Y Sumida","year":"2014","unstructured":"Sumida, Y., Nakajima, A. & Itoh, Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. World J. Gastroenterol.: WJG 20(2), 475 (2014).","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"28","key":"46711_CR15","doi-asserted-by":"publisher","first-page":"26192","DOI":"10.18632\/oncotarget.4613","volume":"6","author":"B Stangeland","year":"2015","unstructured":"Stangeland, B. et al. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Oncotarget 6(28), 26192 (2015).","journal-title":"Oncotarget"},{"issue":"1","key":"46711_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni, G. et al. The Fatty Liver Index: A simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 6(1), 1\u20137 (2006).","journal-title":"BMC Gastroenterol."},{"issue":"3","key":"46711_CR17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jhep.2009.05.023","volume":"51","author":"NF Schwenzer","year":"2009","unstructured":"Schwenzer, N. F. et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J. Hepatol. 51(3), 433\u2013445 (2009).","journal-title":"J. Hepatol."},{"key":"46711_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/978-1-62703-770-9_17","volume-title":"Adipokines in Nonalcoholic Fatty Liver Disease. Adipose Tissue and Adipokines in Health and Disease","author":"A Baranova","year":"2014","unstructured":"Baranova, A., Birerdinc, A. & Younossi, Z. M. Adipokines in Nonalcoholic Fatty Liver Disease. Adipose Tissue and Adipokines in Health and Disease 249\u2013283 (Springer, 2014)."},{"issue":"1","key":"46711_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11892-005-0071-7","volume":"5","author":"Y-H Lee","year":"2005","unstructured":"Lee, Y.-H. & Pratley, R. E. The evolving role of inflammation in obesity and the metabolic syndrome. Curr. Diabetes Rep. 5(1), 70\u201375 (2005).","journal-title":"Curr. Diabetes Rep."},{"key":"46711_CR20","doi-asserted-by":"publisher","DOI":"10.1201\/9781315371658","volume-title":"Machine Learning: Algorithms and Applications","author":"M Mohammed","year":"2016","unstructured":"Mohammed, M., Khan, M. B. & Bashier, E. B. M. Machine Learning: Algorithms and Applications (CRC Press, 2016)."},{"key":"46711_CR21","first-page":"53","volume-title":"Machine Learning Approaches for Biomarker Discovery Using Gene Expression Data","author":"X Zhang","year":"2021","unstructured":"Zhang, X., Jonassen, I. & Goks\u00f8yr, A. Machine Learning Approaches for Biomarker Discovery Using Gene Expression Data 53\u201364 (Exon Publications, 2021)."},{"issue":"5","key":"46711_CR22","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.3390\/ijms22052761","volume":"22","author":"C-H Chang","year":"2021","unstructured":"Chang, C.-H., Lin, C.-H. & Lane, H.-Y. Machine learning and novel biomarkers for the diagnosis of Alzheimer\u2019s disease. Int. J. Mol. Sci. 22(5), 2761 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"46711_CR23","first-page":"23","volume":"4","author":"T Wuest","year":"2016","unstructured":"Wuest, T., Weimer, D., Irgens, C. & Thoben, K.-D. Machine learning in manufacturing: Advantages, challenges, and applications. Prod. Manuf. Res. 4(1), 23\u201345 (2016).","journal-title":"Prod. Manuf. Res."},{"issue":"1","key":"46711_CR24","first-page":"3","volume":"9","author":"KCA Khanzode","year":"2020","unstructured":"Khanzode, K. C. A. & Sarode, R. D. Advantages and disadvantages of artificial intelligence and machine learning: A literature review. Int. J. Libr. Inf. Sci. (IJLIS) 9(1), 3 (2020).","journal-title":"Int. J. Libr. Inf. Sci. (IJLIS)"},{"issue":"1","key":"46711_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33(1), 1 (2010).","journal-title":"J. Stat. Softw."},{"issue":"9","key":"46711_CR26","first-page":"447","volume":"4","author":"A Dorugade","year":"2010","unstructured":"Dorugade, A. & Kashid, D. Alternative method for choosing ridge parameter for regression. Appl. Math. Sci. 4(9), 447\u2013456 (2010).","journal-title":"Appl. Math. Sci."},{"issue":"2","key":"46711_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/ni.2509","volume":"14","author":"MN Lee","year":"2013","unstructured":"Lee, M. N. et al. Identification of regulators of the innate immune response to cytosolic DNA and retroviral infection by an integrative approach. Nat. Immunol. 14(2), 179\u2013185 (2013).","journal-title":"Nat. Immunol."},{"issue":"5","key":"46711_CR28","first-page":"255","volume":"15","author":"EF Carney","year":"2019","unstructured":"Carney, E. F. ABCF1 switches off inflammation in sepsis. Nat. Rev. Nephrol. 15(5), 255\u2013355 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"46711_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.canlet.2019.05.010","volume":"457","author":"SW Fung","year":"2019","unstructured":"Fung, S. W. et al. The ATP-binding cassette transporter ABCF1 is a hepatic oncofetal protein that promotes chemoresistance, EMT and cancer stemness in hepatocellular carcinoma. Cancer Lett. 457, 98\u2013109 (2019).","journal-title":"Cancer Lett."},{"key":"46711_CR30","unstructured":"Cheung, S. T., Cheung, P. F., Cheng, C. K. & Fan, S. T. Genomics approach to identify drug transporter ABCF1 associated with liver cancer recurrence and chemo-resistance: The 103rd Annual Meeting of the American Association for Cancer Research (AACR 2012), Chicago, IL., 31 March-4 April 2012"},{"issue":"12","key":"46711_CR31","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1124\/dmd.111.041012","volume":"39","author":"RN Hardwick","year":"2011","unstructured":"Hardwick, R. N., Fisher, C. D., Canet, M. J., Scheffer, G. L. & Cherrington, N. J. Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease. Drug Metabol. Dispos. 39(12), 2395\u20132402 (2011).","journal-title":"Drug Metabol. Dispos."},{"issue":"10","key":"46711_CR32","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1124\/dmd.107.015107","volume":"35","author":"AJ Lickteig","year":"2007","unstructured":"Lickteig, A. J. et al. Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease. Drug Metabol. Dispos. 35(10), 1970\u20131978 (2007).","journal-title":"Drug Metabol. Dispos."},{"issue":"7","key":"46711_CR33","first-page":"e120","volume":"23","author":"H Kojima","year":"2008","unstructured":"Kojima, H. et al. Disturbed colocalization of multidrug resistance protein 2 and radixin in human cholestatic liver diseases. J. Gastroenterol. Hepatol. 23(7), e120\u2013e128 (2008).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"5","key":"46711_CR34","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0168-8278(03)00410-0","volume":"39","author":"H Kojima","year":"2003","unstructured":"Kojima, H. et al. Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis. J. Hepatol. 39(5), 693\u2013702 (2003).","journal-title":"J. Hepatol."},{"issue":"4","key":"46711_CR35","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/hep.24149","volume":"53","author":"E Mizukoshi","year":"2011","unstructured":"Mizukoshi, E. et al. Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma. Hepatology 53(4), 1206\u20131216 (2011).","journal-title":"Hepatology"},{"issue":"6","key":"46711_CR36","first-page":"7708","volume":"17","author":"L Li","year":"2018","unstructured":"Li, L. et al. Identification of key genes in non-alcoholic fatty liver disease progression based on bioinformatics analysis. Mol. Med. Rep. 17(6), 7708\u20137720 (2018).","journal-title":"Mol. Med. Rep."},{"issue":"10","key":"46711_CR37","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s11745-015-4032-x","volume":"50","author":"J Zhang","year":"2015","unstructured":"Zhang, J. et al. Differential expression of cell cycle regulators during hyperplastic and hypertrophic growth of broiler subcutaneous adipose tissue. Lipids 50(10), 965\u2013976 (2015).","journal-title":"Lipids"},{"issue":"2","key":"46711_CR38","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cmet.2017.12.010","volume":"27","author":"G Benegiamo","year":"2018","unstructured":"Benegiamo, G. et al. The RNA-binding protein NONO coordinates hepatic adaptation to feeding. Cell Metabol. 27(2), 404\u2013418 (2018).","journal-title":"Cell Metabol."},{"key":"46711_CR39","first-page":"58","volume":"12","author":"P Wu","year":"2021","unstructured":"Wu, P., Zhang, M. & Webster, N. J. Alternative RNA splicing in fatty liver disease. Front. Endocrinol. 12, 58 (2021).","journal-title":"Front. Endocrinol."},{"issue":"3","key":"46711_CR40","first-page":"1","volume":"20","author":"M Naderi","year":"2017","unstructured":"Naderi, M. et al. Two triacylglycerol pathway genes, CTDNEP1 and LPIN1, are down-regulated by hsa-miR-122\u20135p in hepatocytes. Arch. Iran. Med. 20(3), 1 (2017).","journal-title":"Arch. Iran. Med."},{"issue":"6","key":"46711_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-021-03818-1","volume":"12","author":"W Zhong","year":"2021","unstructured":"Zhong, W., Liu, H., Deng, L., Chen, G. & Liu, Y. HBO1 overexpression is important for hepatocellular carcinoma cell growth. Cell Death Dis. 12(6), 1\u201313 (2021).","journal-title":"Cell Death Dis."},{"issue":"2","key":"46711_CR42","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/nu13020552","volume":"13","author":"V Esteve-Luque","year":"2021","unstructured":"Esteve-Luque, V. et al. Implication between genetic variants from APOA5 and ZPR1 and NAFLD severity in patients with hypertriglyceridemia. Nutrients 13(2), 552 (2021).","journal-title":"Nutrients"},{"key":"46711_CR43","first-page":"5","volume":"2016","author":"J Wang","year":"2016","unstructured":"Wang, J. et al. GPR21 KO mice demonstrate no resistance to high fat diet induced obesity or improved glucose tolerance. F1000Research 2016, 5 (2016).","journal-title":"F1000Research"},{"issue":"2","key":"46711_CR44","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3390\/biology11020311","volume":"11","author":"RR Pitere","year":"2022","unstructured":"Pitere, R. R., van Heerden, M. B., Pepper, M. S. & Ambele, M. A. Slc7a8 deletion is protective against diet-induced obesity and attenuates lipid accumulation in multiple organs. Biology 11(2), 311 (2022).","journal-title":"Biology"},{"issue":"1","key":"46711_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-15-517","volume":"15","author":"H Zhang","year":"2014","unstructured":"Zhang, H. et al. Detection of genome-wide copy number variations in two chicken lines divergently selected for abdominal fat content. BMC Genom. 15(1), 1\u201312 (2014).","journal-title":"BMC Genom."},{"key":"46711_CR46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.bbrc.2021.09.009","volume":"585","author":"Y Jin","year":"2021","unstructured":"Jin, Y. et al. KAT6A is associated with sorafenib resistance and contributes to progression of hepatocellular carcinoma by targeting YAP. Biochem. Biophys. Res. Commun. 585, 185\u2013190 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"46711_CR47","doi-asserted-by":"publisher","first-page":"100729","DOI":"10.1016\/j.drup.2020.100729","volume":"53","author":"N Wiesel-Motiuk","year":"2020","unstructured":"Wiesel-Motiuk, N. & Assaraf, Y. G. The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology. Drug Resist. Updates 53, 100729 (2020).","journal-title":"Drug Resist. Updates"},{"issue":"1","key":"46711_CR48","doi-asserted-by":"publisher","first-page":"15273","DOI":"10.1038\/s41598-018-33419-6","volume":"8","author":"R Fan","year":"2018","unstructured":"Fan, R., Wang, J. & Du, J. Association between body mass index and fatty liver risk: A dose-response analysis. Sci. Rep. 8(1), 15273. https:\/\/doi.org\/10.1038\/s41598-018-33419-6 (2018).","journal-title":"Sci. Rep."},{"issue":"1","key":"46711_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-33419-6","volume":"8","author":"R Fan","year":"2018","unstructured":"Fan, R., Wang, J. & Du, J. Association between body mass index and fatty liver risk: A dose-response analysis. Sci. Rep. 8(1), 1\u20137 (2018).","journal-title":"Sci. Rep."},{"issue":"1","key":"46711_CR50","doi-asserted-by":"publisher","first-page":"859","DOI":"10.5812\/ircmj.12669","volume":"16","author":"G Abangah","year":"2014","unstructured":"Abangah, G. et al. Correlation of body mass index and serum parameters with ultrasonographic grade of fatty change in non-alcoholic fatty liver disease. Iran. Red Crescent Med. J. 16(1), 859 (2014).","journal-title":"Iran. Red Crescent Med. J."},{"key":"46711_CR51","first-page":"859","volume":"2023","author":"G Pourali","year":"2023","unstructured":"Pourali, G. et al. Therapeutic potential of herbal medicine against non-alcoholic fatty liver disease. Curr. Drug Targets 2023, 859 (2023).","journal-title":"Curr. Drug Targets"},{"issue":"8","key":"46711_CR52","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3748\/wjg.v19.i8.1158","volume":"19","author":"M Basaranoglu","year":"2013","unstructured":"Basaranoglu, M., Basaranoglu, G. & Sent\u00fcrk, H. From fatty liver to fibrosis: A tale of \u201csecond hit\u201d. World J. Gastroenterol.: WJG 19(8), 1158 (2013).","journal-title":"World J. Gastroenterol.: WJG"},{"key":"46711_CR53","doi-asserted-by":"publisher","first-page":"120760","DOI":"10.1016\/j.lfs.2022.120760","volume":"305","author":"N Zafari","year":"2022","unstructured":"Zafari, N. et al. Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: Molecular mechanisms, biomarkers, and therapeutic prospective. Life Sci. 305, 120760. https:\/\/doi.org\/10.1016\/j.lfs.2022.120760 (2022).","journal-title":"Life Sci."},{"issue":"6","key":"46711_CR54","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","volume":"158","author":"RS Taylor","year":"2020","unstructured":"Taylor, R. S. et al. Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis. Gastroenterology 158(6), 1611\u20131625 (2020).","journal-title":"Gastroenterology"},{"issue":"12","key":"46711_CR55","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1111\/jgh.15627","volume":"36","author":"J Pan","year":"2021","unstructured":"Pan, J. et al. Insulin-like growth factor binding protein 1 ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease. J. Gastroenterol. Hepatol. 36(12), 3438\u20133447 (2021).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"34","key":"46711_CR56","doi-asserted-by":"publisher","first-page":"30003","DOI":"10.1074\/jbc.M110.184697","volume":"286","author":"VR Holla","year":"2011","unstructured":"Holla, V. R., Wu, H., Shi, Q., Menter, D. G. & DuBois, R. N. Nuclear orphan receptor NR4A2 modulates fatty acid oxidation pathways in colorectal cancer. J. Biol. Chem. 286(34), 30003\u201330009 (2011).","journal-title":"J. Biol. Chem."},{"key":"46711_CR57","doi-asserted-by":"publisher","first-page":"e1518","DOI":"10.7717\/peerj.1518","volume":"3","author":"P Chen","year":"2015","unstructured":"Chen, P. et al. Orphan nuclear receptor NR4A2 inhibits hepatic stellate cell proliferation through MAPK pathway in liver fibrosis. PeerJ 3, e1518 (2015).","journal-title":"PeerJ"},{"key":"46711_CR58","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cmpb.2018.12.032","volume":"170","author":"C-C Wu","year":"2019","unstructured":"Wu, C.-C. et al. Prediction of fatty liver disease using machine learning algorithms. Comput. Methods Progr. Biomed. 170, 23\u201329 (2019).","journal-title":"Comput. Methods Progr. Biomed."},{"key":"46711_CR59","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1155\/2018\/4304376","volume":"2018","author":"H Ma","year":"2018","unstructured":"Ma, H., Xu, C.-F., Shen, Z., Yu, C.-H. & Li, Y.-M. Application of machine learning techniques for clinical predictive modeling: A cross-sectional study on nonalcoholic fatty liver disease in China. BioMed Res. Int. 2018, 9 (2018).","journal-title":"BioMed Res. Int."},{"key":"46711_CR60","first-page":"1","volume":"2023","author":"G Khalili-Tanha","year":"2023","unstructured":"Khalili-Tanha, G. et al. Identification of ZMYND19 as a novel biomarker of colorectal cancer: RNA-sequencing and machine learning analysis. J. Cell Commun. Signal. 2023, 1\u201317 (2023).","journal-title":"J. Cell Commun. Signal."},{"issue":"1","key":"46711_CR61","doi-asserted-by":"publisher","first-page":"100907","DOI":"10.1016\/j.tranon.2020.100907","volume":"14","author":"Y Xie","year":"2021","unstructured":"Xie, Y. et al. Early lung cancer diagnostic biomarker discovery by machine learning methods. Transl. Oncol. 14(1), 100907 (2021).","journal-title":"Transl. Oncol."},{"issue":"4","key":"46711_CR62","doi-asserted-by":"publisher","first-page":"320","DOI":"10.2174\/1574893618666230227103427","volume":"18","author":"E Nazari","year":"2023","unstructured":"Nazari, E. et al. Identification of potential biomarkers in stomach adenocarcinoma using machine learning approaches. Curr. Bioinform. 18(4), 320\u2013333 (2023).","journal-title":"Curr. Bioinform."},{"issue":"12","key":"46711_CR63","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/genes9120641","volume":"9","author":"MV Dogan","year":"2018","unstructured":"Dogan, M. V. et al. Blood-based biomarkers for predicting the risk for five-year incident coronary heart disease in the Framingham Heart Study via machine learning. Genes 9(12), 641 (2018).","journal-title":"Genes"},{"issue":"3","key":"46711_CR64","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1172\/JCI131838","volume":"130","author":"AM Poss","year":"2020","unstructured":"Poss, A. M. et al. Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease. J. Clin. Investig. 130(3), 1363\u20131376 (2020).","journal-title":"J. Clin. Investig."},{"key":"46711_CR65","doi-asserted-by":"publisher","first-page":"740513","DOI":"10.3389\/fimmu.2022.740513","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Machine-learning algorithm-based prediction of diagnostic gene biomarkers related to immune infiltration in patients with chronic obstructive pulmonary disease. Front. Immunol. 13, 740513 (2022).","journal-title":"Front. Immunol."},{"issue":"2","key":"46711_CR66","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3390\/genes14020284","volume":"14","author":"K-R Dhong","year":"2023","unstructured":"Dhong, K.-R., Lee, J.-H., Yoon, Y.-R. & Park, H.-J. Identification of TRPC6 as a novel diagnostic biomarker of pm-induced chronic obstructive pulmonary disease using machine learning models. Genes 14(2), 284 (2023).","journal-title":"Genes"},{"issue":"1","key":"46711_CR67","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41531-020-00127-w","volume":"6","author":"C Su","year":"2020","unstructured":"Su, C., Tong, J. & Wang, F. Mining genetic and transcriptomic data using machine learning approaches in Parkinson\u2019s disease. NPJ Parkinson\u2019s Dis. 6(1), 24 (2020).","journal-title":"NPJ Parkinson's Dis."},{"key":"46711_CR68","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1155\/2020\/8348147","volume":"2020","author":"J Ren","year":"2020","unstructured":"Ren, J., Zhang, B., Wei, D. & Zhang, Z. Identification of methylated gene biomarkers in patients with Alzheimer\u2019s disease based on machine learning. BioMed Res. Int. 2020, 11 (2020).","journal-title":"BioMed Res. Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46711-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46711-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46711-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T16:13:11Z","timestamp":1700669591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46711-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,22]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["46711"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-46711-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,22]]},"assertion":[{"value":"10 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20489"}}